RecruitingNCT00064870

Alzheimer's Disease Genetics Study

National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)


Sponsor

Indiana University

Enrollment

10,000 participants

Start Date

Jun 1, 2002

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of the Alzheimer's Disease Genetics Study is to identify the genes that are responsible for causing Alzheimer's Disease (AD). One of the ways in which the risk factor genes for late onset AD can be investigated is by identifying and collecting genetic material from families with multiple members diagnosed with AD or dementia.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting genetic material from families affected by Alzheimer's disease to identify genes that may increase the risk of developing the condition. **You may be eligible if...** - Your family has at least two living members diagnosed with Alzheimer's disease or another form of dementia - Biological samples are available (such as a blood sample, cell line, or frozen brain tissue) **You may NOT be eligible if...** - Your family was already included in the National Institute of Mental Health Alzheimer's Genetics Sib Pair collection - You do not meet the inclusion criteria above Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Participants are being recruited from all over the United States

Nationwide, Indiana, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00064870


Related Trials